1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Adrenal Cortex Diseases: new trials by email Literature Review of Adrenal Cortex Diseases trials Research Report on Adrenal Cortex Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IPI-549 IPI-549 (eganelisib), Nivolumab - Advanced Solid Tumors (Part A/B/C/D), Non-small Cell Lung Cancer (Part E) | Phase 1 | Unknown | Infinity Pharmaceuticals, Inc. | 219 | 2015-12-01 | 2022-04-04 |
Adrenocortical Carcinoma (1) · Carcinoma, Non-Small-Cell Lung (1) · Melanoma (1) · Mesothelioma (1) · Triple Negative Breast Neoplasms (1)
Adenocarcinoma (1) · Adenoma (1) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1) · Breast Diseases (1) · Breast Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma (1) · Carcinoma, Bronchogenic (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Lung Diseases (1) · Lung Neoplasms (1)
Infinity Pharmaceuticals, Inc. (1)
United States (1)
Feng Chi, MD (1)